The interim result of a phase I/II study of nivolumab with or without ipilimumab in combination with multi-fraction stereotactic radiosurgery for recurrent, high-grade, radiation-relapsed meningioma.
Year: 2022
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: Washington University in St. Louis, UPMC Health System, UPMC Hillman Cancer Center, University of Pittsburgh Medical Center, University of North Carolina at Chapel Hill, University of Colorado Denver, The University of Kansas Health System, Memorial Sloan Kettering Cancer Center, National Institutes of Health, National Cancer Institute, Mayo Clinic
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: National Institutes of Health
OpenAlex ID: W4286294575